-
Mashup Score: 0
Some fun photos and sights from 2025 AACR/AACI Hill Day. The National Institutes of Health (NIH) National Cancer Institute (NCI) #AACRontheHill #FundNIH #AACIontheHill American Association for Cancer Research (AACR) AACI (Association of American Cancer Institutes)
Source: www.linkedin.comCategories: General Medicine NewsTweet
-
Mashup Score: 8Proteomic Risk Scores Improve Prediction of Atrial Fibrillation: Evidence from Large-Scale Cohorts - 13 hour(s) ago
Atrial fibrillation is a growing public health challenge worldwide. Current clinical, genetic, and biomarker-based models have improved risk prediction, but there remains room for better strategies to identify individuals at risk.
Source: www.linkedin.comCategories: General Medicine NewsTweet-
Check out my latest article: Proteomic Risk Scores Improve Prediction of Atrial Fibrillation: Evidence from Large-Scale Cohorts https://t.co/ZW51KAndSe via @LinkedIn
-
-
Mashup Score: 0Elsevier Health and Medical Sciences Journals | LinkedIn - 18 hour(s) ago
Elsevier Health and Medical Sciences Journals | 10 followers on LinkedIn. –
Source: www.linkedin.comCategories: General Medicine NewsTweet-
Dear followers, we are transitioning from X and will be closing this account shortly. Don't miss out on our updates! Follow us on LinkedIn and BlueSky. 🔗LinkedIn:https://t.co/1hUA7YZyyW 🔗BlueSky:https://t.co/xeYfF8N6I7
-
-
Mashup Score: 11Moving the dial on diagnostics | The Lancet Group - 19 hour(s) ago
🌏 Nearly half of the global population lack access to basic diagnostics—the staggering reality highlighted by the Lancet Commission on diagnostics. In low-income and lower middle-income countries, this figure soars to 81% 📈 Three years since the Commission was launched, what progress has been made? Find out in this article ⤵️
Source: www.linkedin.comCategories: General Medicine NewsTweet-
🌏 Nearly 1/2 of the global population lack access to basic #diagnostics—the staggering reality highlighted by a 2021 Lancet Commission. In low-income and lower middle-income countries, this figure soars to 81% 📈 Has any progress has been made? ⤵️ https://t.co/Z3pbTZ4vGs
-
-
Mashup Score: 1The Problem with Residual Symptoms for Patients with MDD: Focus on Insomnia | LinkedIn - 1 day(s) ago
See who else is going to The Problem with Residual Symptoms for Patients with MDD: Focus on Insomnia, and keep up-to-date with conversations about the
Source: www.linkedin.comCategories: General Medicine News, PsychiatryTweet-
𝐖𝐚𝐭𝐜𝐡 𝐋𝐈𝐕𝐄 𝐢𝐧 𝟏 𝐇𝐨𝐮𝐫! ➡️ https://t.co/gfpiNHeKyA 😳 Residual symptoms like insomnia can significantly disrupt QOL for patients with major depressive disorder. Hear firsthand experiences and expert insights on managing residual symptoms in this LIVE chat! https://t.co/WCRQ4rk9Ya
-
-
Mashup Score: 4#asco25 #asco #smmtnewera #ivonescimab #teamsummit #cancerresearch… | Summit Therapeutics, Inc. - 2 day(s) ago
#ASCO25 is almost here! Are you attending? If so, our fabulous team members at Summit would love to meet with you. See you in Chicago at our Summit Medical Affairs Booth #36145! #ASCO #SMMTNewEra #Ivonescimab #TeamSummit #CancerResearch #oncology To learn more about Summit’s Phase 3 clinical trials: https://lnkd.in/eQmzGtps For more information on the congresses Team Summit is attending: https://lnkd.in/g5uAQHJ2 *Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).
Source: www.linkedin.comCategories: General Medicine NewsTweet-
#ASCO25 is almost here! https://t.co/kQ9mjxThef
-
-
Mashup Score: 2SCCM Journals | LinkedIn - 2 day(s) ago
SCCM Journals | 158 followers on LinkedIn. Premier peer-reviewed publications aimed at improving the care of all critically ill and injured patients. | The Society of Critical Care Medicine’s (SCCM) scientific journals share the latest research and innovative findings that continually improve the practice of critical care. Critical Care Medicine, Pediatric Critical Care Medicine, and Critical Care Explorations offer: • Peer-reviewed articles written by experts in the field of critical care • Trusted and globally recognized resources with the latest research on innovative therapies and novel approaches in critical care • Visual abstracts, supplemental digital content, and videos for selected articles that synthesize content and highlight key findings
Source: www.linkedin.comCategories: General Medicine NewsTweet-
Have you checked out the new SCCM Journals page on LinkedIn? Get the latest updates on issue releases, featured articles, videos from the editors, and more all in one place. Follow today! ➡️ https://t.co/IYXcpPVkKd #SCCM https://t.co/hTRtwiE10L
-
-
Mashup Score: 0Fired - 2 day(s) ago
I speak around the world and a common question revolves my work today and how I got here. Recently I started answering with a humorist partial truth.
Source: www.linkedin.comCategories: General Medicine NewsTweet-
Fired. https://t.co/cBmVeucuze
-
-
Mashup Score: 1Hi All, Craig Maxwell started his next incredible challenge this morning —… | Magda Meissner MD PhD - 2 day(s) ago
Hi All, Craig Maxwell started his next incredible challenge this morning — rowing from Tenby to Cardiff! He’s continuing his inspiring mission to support QuicDNA Max study that will expand access to ctDNA testing for more cancer types. Please support him if you can — every bit helps! 😊https://lnkd.in/ebvDUUTg
Source: www.linkedin.comCategories: General Medicine NewsTweet-
https://t.co/KF1jHANFMZ
-
-
Mashup Score: 19#efsd #diabetesresearch #funding #precisionmedicine #mody | European Association for the Study of Diabetes e.V. (EASD) - 3 day(s) ago
Congratulations to Dr. V. Mohan Diabetes Specialist and his team at the Madras Diabetes Research Foundation on their recent discovery of a new subtype of monogenic diabetes – an important advancement in diabetes research. Dr. Mohan is a 2023 recipient of the #EFSD and Eli Lilly and Company EXPLORING AND APPLYING NEW STRATEGIES IN DIABETES (EXPAND) Programme grant for his project using deep learning to predict chronic kidney disease from retinal images in people with type 2 diabetes. We wish Dr. Mohan and his colleagues every success as they continue their pioneering work in the field. 📖 Read the publication 👉 https://lnkd.in/d46qpVQk Find out more about EFSD’s funding opportunities 👉 https://lnkd.in/d-QvCStf #DiabetesResearch #Funding #PrecisionMedicine #MODY
Source: www.linkedin.comCategories: General Medicine News, EndocrinologyTweet-
🎉Congratulations to Dr. Viswanathan Mohan (2023 #EFSD/ @EliLillyandCo EXPAND grant recipient) & team at the Madras Diabetes Research Foundation (🇮🇳) on discovering a new subtype of monogenic diabetes - a major advancement in #diabetes research. More🔗👉 https://t.co/njSba92u4n
-
Some fun photos and sights from 2025 AACR/AACI Hill Day. @NIH @theNCI #AACRontheHill #FundNIH #AACIontheHill @AACR @AACI_Cancer https://t.co/0FyrhafkGP